Clinical Trial Update: AIPH-TB: AI-Optimised Pyrazinamide-Hydroxychloroquine vs Standard RIPE for Drug-Sensitive Pulmonary Tuberculosis - A Phase II RCT [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 randomized study comparing AI-optimized pyrazinamide-hydroxychloroquine to the standard RIPE regimen for drug-sen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• Ethambutol (ethambutol)
• Hydroxychloroquine (hydroxychloroquine)
• ISONIAZID (ISONIAZID)
• Pyrazinamide (pyrazinamide)
• RIFAMPIN (RIFAMPIN)

Snippet

Sponsor: Ministry of Health, Saudi Arabia | Conditions: Pulmonary Tuberculosis | Phase 2 | Status: NOT_YET_RECRUITING